SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Robert Peary — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientRobert Peary
Date of birth1856-05-06
IdentifiersMRN HR-EX004-SYN-TD; SSN (made up) 000-04-7351
Document date1919-03-10
AuthorThaddeus Lindgren-Okafor, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Eight-week review: blood count, methylmalonic acid, iron studies and the biopsy results. [S]

History of Present Illness

Admiral Peary returns eight weeks after starting treatment. He feels close to his old self, walks a mile with his stick and has no breathlessness. The tingling has mostly gone, but the ends of his feet remain numb and he is still unsteady in the dark. He has given himself all his weekly injections. He has had no falls and no new foot wounds. The biopsies from his endoscopy show autoimmune atrophic gastritis: atrophy of the body of the stomach with intestinal metaplasia and enterochromaffin-like cell hyperplasia, a normal antrum, no Helicobacter pylori on special stains, and no neuroendocrine tumor or dysplasia. He has no indigestion and no black stools. [S]

ElementDetail
Hemoglobin14.1 g/dL; MCV 91 fL
Response markersMethylmalonic acid 0.26 µmol/L; homocysteine 11
IronFerritin 24 ng/mL; transferrin saturation 14%
BiopsiesAutoimmune atrophic gastritis; no neuroendocrine tumor or dysplasia
FeetNumbness at the ends persists; no wounds; no falls

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy back to near normal
GastrointestinalNegativeNo indigestion, black stools or weight loss
NeurologicalPositiveNumbness at the ends of the feet; unsteady in the dark
PsychiatricNegativeMood good

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection every other day for seven doses, given by the clinic nurse after the intake blood tests were drawn1,000 micrograms into the muscle every other day, seven dosesIntramuscular route1919-01-13 to 1919-01-25completedS
Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a week while the nerves recover1,000 micrograms into the muscle once a week, self-injected after teachingIntramuscular route1919-02-01 to 1919-04-26completedS
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet every other day on an empty stomach with a glass of orange juiceOne tablet every other day, apart from tea and coffee, for three months after the ferritin is normalOral route1919-03-10activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1919-03-10Body height183cmS
1919-03-10Body weight74kgS
1919-03-10Body mass index (BMI) [Ratio]22.1kg/m2S
1919-03-10Systolic blood pressure128mm[Hg]S
1919-03-10Diastolic blood pressure74mm[Hg]S
1919-03-10Heart rate74/minS
1919-03-10Respiratory rate14/minS
1919-03-10Body temperature36.6CelS
1919-03-10Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1919-03-10Hemoglobin [Mass/volume] in Blood14.1g/dL13.2-17.1 g/dLNormalS
1919-03-10MCV [Entitic mean volume] in Red Blood Cells by Automated count91fL80-100 fLNormalS
1919-03-10Erythrocyte [DistWidth] in Blood by Automated count15.6%11-15%HighS
1919-03-10Leukocytes [#/volume] in Blood by Automated count6.210*3/uL3.8-10.8 10*3/uLNormalS
1919-03-10Platelets [#/volume] in Blood by Automated count24810*3/uL140-400 10*3/uLNormalS
1919-03-10Methylmalonate [Moles/volume] in Serum or Plasma0.26umol/L<=0.4 umol/LNormalS
1919-03-10Homocysteine [Moles/volume] in Serum or Plasma11umol/L<=15 umol/LNormalS
1919-03-10Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma190U/L120-250 U/LNormalS
1919-03-10Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL0.2-1.2 mg/dLNormalS
1919-03-10Ferritin [Mass/volume] in Serum or Plasma24ng/mL30-400 ng/mLLowS
1919-03-10Iron [Mass/volume] in Serum or Plasma52ug/dL50-180 ug/dLNormalS
1919-03-10Iron binding capacity [Mass/volume] in Serum or Plasma382ug/dL250-425 ug/dLNormalS
1919-03-10Iron saturation [Mass Fraction] in Serum or Plasma14%20-50%LowS

Physical Exam

Vital signs recorded on 1919-03-10; see the Vital Signs section. [S]

SystemFinding
GeneralGood color; blood pressure 128/74, pulse 74
NeurologicalVibration reduced but present at the ankles; joint position sense normal; ankle jerks absent; Romberg sway without falling; Timed Up and Go 11 seconds
FeetSkin intact; small callus under the right first metatarsal head; monofilament felt at 6 of 10 sites on each forefoot

Problems

ProblemClinical statusVerificationCodeProvenance
Fatigue, breathlessness on exertion, pallor with a lemon-yellow tinge, a sore tongue, and numbness and unsteadiness in the feet over about four months, with a macrocytic anemia, low white cells and platelets, a low vitamin B12 and a high methylmalonic acid; cause under evaluation with a hematology consultationresolvedconfirmed D51.9S — Synthetic presenting problem anchored to the documented pernicious anemia of his last years; superseded when the consultation confirmed pernicious anemia.
Pernicious anemia (autoimmune gastritis with intrinsic factor antibodies), with severe vitamin B12 deficiency; synthetic modern diagnosis linked to the documented cause of his deathactiveconfirmed D51.0S — Synthetic modern diagnosis made at the consultation, anchored to his documented death from pernicious anemia; the timing and course in the modern episode are synthetic.
Subacute combined degeneration of the spinal cord with peripheral neuropathy from vitamin B12 deficiency: loss of vibration and joint position sense in the feet, absent ankle jerks, brisk knee jerks and a positive Romberg testactiveconfirmed G32.0S — Synthetic neurological complication; not a claim about his real nerves.
Absence of the second to fifth toes of the right foot after frostbite and amputation in early middle age; healed stumps; callus under the first metatarsal headactiveconfirmed Z89.421S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007).
Absence of the second to fifth toes of the left foot after frostbite and amputation in early middle age; healed stumpsactiveconfirmed Z89.422S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007).
One fall in a dark bedroom a month ago without injury; unsteady in the dark and on uneven ground; uses a stick outdoorsactiveconfirmed Z91.81S — Synthetic fall linked to the neuropathy and the old toe amputations.
Autoimmune atrophic gastritis, corpus-predominant, with intestinal metaplasia and enterochromaffin-like cell hyperplasia in the body of the stomach, a spared antrum, no Helicobacter pylori, no neuroendocrine tumor and no dysplasiaactiveconfirmed K29.40S — Synthetic endoscopy and pathology result, the cause of the pernicious anemia; not a claim about his real stomach.
Iron deficiency without anemia, unmasked by the recovery of red cell production and the poor iron absorption of atrophic gastritis; colonoscopy and endoscopy without a bleeding sourceactiveconfirmed E61.1S — Synthetic finding at eight weeks.
Blister on the end of the left forefoot over the old amputation stump, from boots not yet broken in, in a foot with reduced sensation; no infection; healed in two weeksresolvedconfirmed S90.822AS — Synthetic acute foot problem; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveySymptoms: fatigue, breathlessness, exercise tolerance, sore tongue, numbnessEvery visit during active treatmentCompleted todayNo fatigue or breathlessness; numbness at the ends of the feet
LaboratoryBlood count with MCVAbout eight weeks after starting replacement, with earlier checks in severe anemiaCompleted todayHemoglobin 14.1 g/dL, MCV 91 fL, RDW 15.6%, white cells 6.2, platelets 248: normalized
LaboratoryMethylmalonic acid and homocysteineOne week to three months after starting replacementCompleted todayMethylmalonic acid 0.26 µmol/L and homocysteine 11 µmol/L, normal; LDH 190 U/L and bilirubin 0.7 mg/dL, normal
LaboratorySerum vitamin B12Not routinely after replacement startsNot indicatedNot rechecked once treatment is established
LaboratoryIron studies (ferritin, transferrin saturation)When the blood count recovers, and about three months into oral ironCompleted todayFerritin 24 ng/mL, iron 52 µg/dL, TIBC 382 µg/dL, saturation 14%: iron deficiency; oral iron started
Medication safetyInjection plan: doses given, self-injection technique, site problemsEvery visitCompleted todayAll weekly self-injections given
ExaminationNeurological examination: vibration, joint position, reflexes, Romberg, gait, cognitionAt diagnosis and at follow-up visits for six weeks to three months, then until recovery levels offCompleted todayVibration returning at the ankles; Romberg sway; ankle jerks still absent
ExaminationFalls and gait: falls since the last visit, Timed Up and Go, home hazardsEvery visitCompleted todayNo falls; Timed Up and Go 11 seconds
ExaminationUpper endoscopy with Sydney-protocol biopsies for autoimmune gastritis, neuroendocrine tumors and dysplasiaAt diagnosis of pernicious anemia; then by individual riskCompleted todayBiopsies: autoimmune atrophic gastritis with intestinal metaplasia and enterochromaffin-like cell hyperplasia; no Helicobacter pylori, neuroendocrine tumor or dysplasia; surveillance every three years by shared decision
LaboratoryAutoimmune screening: TSH and thyroid antibodies; HbA1cAt diagnosis, then TSH yearlyUp to dateTSH 2.6, thyroid antibody negative and HbA1c 5.5% at diagnosis; TSH due in a year
Self-managementFeet: daily skin checks, footwear, callus and stump skin, monofilamentEvery visitCompleted todaySkin intact; monofilament felt at 6 of 10 sites on each forefoot
ReferralPhysical therapy for balance and gaitFrom diagnosis until balance recoversCompleted todayTwice a week; home program

Goal progress:

Guideline basis: Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014); Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024); AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021); CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026); Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update) (2023); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024)

Follow-up: Preventive visit in two weeks. Fifteen-week review with the blood count and iron studies. Continue weekly injections. Next scheduled visit 1919-03-24: periodic adult preventive visit. [S]